Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

KRH-594, a new angiotensin antagonist, evaluated in animal models of hypertension

Feb. 3, 1999

Improved salts of ACE inhibitors prepared at NicOx

Feb. 3, 1999

New series of NHE inhibitors in development at Synthelabo

Feb. 3, 1999

Pharmacological characterization of fluodipine: a new selective bradycardic agent

Feb. 2, 1999

Genetix and Cordis to develop angiogenic gene therapy products for cardiovascular disease

Feb. 1, 1999

Increased PKC activity activity and role for PKC-beta inhibitors in heart failure

Feb. 1, 1999

FDA advisory committee recommends approval of Natrecor

Feb. 1, 1999

Phase III trial for angina treatment begins at international sites

Feb. 1, 1999

New cardiac antiischemic agents developed by Lederle in Japan

Jan. 29, 1999

Procter & Gamble will collaborate with Alexion on development of 5G1.1-SC

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.